Related Announcements

PAR-22-027 - Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to remove "No late applications will be accepted for this Funding Opportunity Announcement" language from Funding Opportunity Announcement (FOA) PAR-22-027, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)".

The following modification has been made to PAR-22-027:

Currently Reads:

Part 1. Overview Information

Key Dates

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

No late applications will be accepted for this Funding Opportunity Announcement.

Modified to Read:

Part 1. Overview Information

Key Dates

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Marsha F. Lopez, PhD, MHS
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504 
Email: [email protected]